The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Keller Eric L.

Reporting owner CIK 0002156365 · CHIEF EXECUTIVE OFFICER · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Keller Eric L.Keller Eric L.Keller Eric L. · October 13, 2026 · Stock award · Stock Option (right to buy)Keller Eric L. · October 13, 2026 · Conversion · Common StockKeller Eric L. · October 13, 2026 · Conversion · Common StockKeller Eric L. · October 13, 2026 · Purchase · Common StockOct 13, 2026Oct 13, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 13, 2026Retension Pharmaceuticals, Inc.Stock Option (right to buy)Keller Eric L.Stock award
Oct 13, 2026Retension Pharmaceuticals, Inc.Common StockKeller Eric L.Conversion
Oct 13, 2026Retension Pharmaceuticals, Inc.Common StockKeller Eric L.Conversion
Oct 13, 2026Retension Pharmaceuticals, Inc.Common StockKeller Eric L.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Keller Eric L.CHIEF EXECUTIVE OFFICER · Director
Stock awardStock Option (right to buy)Derivative security · Code A255,1740Value: 0Currency not specifiedView ↗
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Keller Eric L.CHIEF EXECUTIVE OFFICER · Director
ConversionCommon StockNon-derivative security · Code C31,368Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Keller Eric L.CHIEF EXECUTIVE OFFICER · Director
ConversionCommon StockNon-derivative security · Code C9,662Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Retension Pharmaceuticals, Inc.RTSN · company listings
Keller Eric L.CHIEF EXECUTIVE OFFICER · Director
PurchaseCommon StockNon-derivative security · Code P20,80012Value: 249,600Currency not specifiedView ↗